Lb Pharmaceuticals (LBRX) Prepaid Assets (2024 - 2026)

Lb Pharmaceuticals' (LBRX) quarterly Prepaid Assets came in at $23.4 million in Q1 2026, up 4232.35% quarter-over-quarter from $541000.0 in Q4 2025.

Lb Pharmaceuticals (LBRX) Prepaid Assets (2024 - 2026) Analysis & Trends

Lb Pharmaceuticals' Prepaid Assets history runs 3 years deep, the most recent figure standing at $23.4 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets changed N/A year-over-year to $23.4 million in Q1 2026; TTM through Mar 2026 was $23.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $541000.0, up 849.12% from the prior year.
  • Prepaid Assets advanced to $23.4 million in Q1 2026 per LBRX's latest filing, from $541000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $23.4 million in Q1 2026 and bottomed at $57000.0 in Q4 2024.
  • The 3-year median for Prepaid Assets is $1.2 million (2025), against an average of $6.5 million.
  • Biggest YoY gain for Prepaid Assets was 849.12% in 2025; the steepest drop was 849.12% in 2025.
  • Year by year, Prepaid Assets stood at $57000.0 in 2024, then jumped by 849.12% to $541000.0 in 2025, then soared by 4232.35% to $23.4 million in 2026.
  • Per Business Quant, the three latest LBRX Prepaid Assets figures stand at $23.4 million (Q1 2026), $541000.0 (Q4 2025), and $1.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Lb Pharmaceuticals 977.73 Mn 977.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 23.44 Mn
Dec 31, 2025 541,000.00
Sep 30, 2025 1.92 Mn
Dec 31, 2024 57,000.00